Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (the "Shares") (TERN)

Historical Holders from Q1 2021 to Q1 2025

Symbol
TERN on Nasdaq
CUSIP
880881107
Type / Class
Equity / Common Stock, $0.0001 par value per share (the "Shares")
Shares outstanding
84.5M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
86.1M
Holdings value
$477M
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
155
Number of buys
92
Number of sells
-68
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (the "Shares") (TERN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Soleus Capital Master Fund, L.P. 9.6% $27.6M 8.14M Soleus Capital Master Fund, L.P. Dec 31, 2024
BlackRock, Inc. 6.8% $19.5M 5.74M BlackRock, Inc. Dec 31, 2024
Schonfeld Strategic Advisors LLC 6.16% $17.7M 5.23M Schonfeld Strategic Advisors LLC Dec 31, 2024
CITADEL ADVISORS LLC 4.1% $11.7M 3.47M Kenneth Griffin Dec 31, 2024

Institutional Holders of Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (the "Shares") (TERN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 1.11M $3.06M +$1.12M $2.76 9
2024 Q4 86.1M $477M +$3.71M $5.54 155
2024 Q3 79.5M $663M +$119M $8.34 154
2024 Q2 65.6M $447M +$18.1M $6.81 124
2024 Q1 63.1M $414M +$5.04M $6.56 111
2023 Q4 63.6M $413M +$12.1M $6.49 102
2023 Q3 61.3M $308M +$7.25M $5.03 91
2023 Q2 57.6M $504M +$30.4M $8.75 101
2023 Q1 53.2M $630M +$46.1M $11.84 79
2022 Q4 49.7M $506M +$197M $10.18 64
2022 Q3 30.2M $178M +$107M $5.89 43
2022 Q2 14.7M $36.4M -$5.9M $2.48 34
2022 Q1 16.8M $49.9M -$1.4M $2.97 42
2021 Q4 16.5M $117M -$4.53M $7.07 37
2021 Q3 16.7M $174M -$738K $10.42 33
2021 Q2 16.6M $204M -$23.6M $12.26 36
2021 Q1 17.9M $394M +$393M $22.00 42